DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas

Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity

(2013) Lifang Yang et al.   CANCER BIOLOGY & THERAPY

Potential use of nucleic acid-based agents in the sensitization of nasopharyngeal carcinoma to radiotherapy

(2012) Lu Zhang et al.   CANCER LETTERS

Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies

(2012) James P. B. O'Connor et al.   Nature Reviews Clinical Oncology

Current understanding and management of nasopharyngeal carcinoma

(2011) Tomokazu Yoshizaki et al.   AURIS NASUS LARYNX

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

(2011) Olivier Keunen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapy

(2010) C. L. Mitchell et al.   ANNALS OF ONCOLOGY

A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics

(2010) Claire L. Mitchell et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling

(2010) Zhenlian Wang et al.   EUROPEAN JOURNAL OF CANCER

EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model

(2010) Xia Ke et al.   MEDICAL ONCOLOGY

A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers

(2009) J. Baar et al.   CLINICAL CANCER RESEARCH

Quantifying Antivascular Effects of Monoclonal Antibodies to Vascular Endothelial Growth Factor: Insights from Imaging

(2009) J. P.B. O'Connor et al.   CLINICAL CANCER RESEARCH

Role of the Epstein–Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma

(2009) Mhairi A Morris et al.   Future Oncology

Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225

(2009) Nancy Lee et al.   JOURNAL OF CLINICAL ONCOLOGY

The role of clinical imaging in oncological drug development

(2008) P S MURPHY et al.   BRITISH JOURNAL OF RADIOLOGY

DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma

(2008) Zhong-Xin Lu et al.   CANCER LETTERS

Deoxyribozymes: useful DNA catalysts in vitro and in vivo

(2008) D. A. Baum et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Catalytic DNA (deoxyribozymes) for synthetic applications—current abilities and future prospects

(2008) Scott K. Silverman   CHEMICAL COMMUNICATIONS

Perfusion characteristics of late radiation injury of parotid glands: quantitative evaluation with dynamic contrast-enhanced MRI

(2008) Chun-Jung Juan et al.   EUROPEAN RADIOLOGY

Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors

(2008) Patricia M. LoRusso et al.   INVESTIGATIONAL NEW DRUGS